Glucose in Dialysis Water in Non-diabetics

Regional Hospital Holstebro18 enrolled

Overview

The purposes are 1. to measure the effect of dialysis with glucose on blood pressure, pulse rate, plasma concentration of glucose, plasma concentrations of glucagon, growth hormone, renin, angiotensin II, endothelin and body temperature, and 2. to analysis the relationship between changes in blood pressure on the one hand and changes in vasoactive hormones on the other

Measurement of hormones and blood pressure during dialysis treatment.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Renal Failure, Chronic

Interventions

dialysis with glucose in dialysis waterPROCEDURE

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Age \> 18 years, 2. Both men and women, 3. Dialysis treatment for at least three months Exclusion Criteria: 1. Heart failure, 2. Chronic liver disease, 3. Diabetes mellitus, 4. Malignant disease, 5. Nephrotic syndrome, 6. Lack of compliance, 7 Unwillingness to participate

Locations (1)

Holstebro Hospital

Holstebro, Denmark

Outcomes

Primary Outcomes

Effect of glucose in dialysis water on blood pressure, insulin and vasoactive hormones

Time frame: one week

Secondary Outcomes

Relationship between changes in blood pressure and changes in hormones during treatment

Time frame: one week

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.